These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 12124823)
1. Influence of p53 mutations on prognosis of patients with glioblastoma. Shiraishi S; Tada K; Nakamura H; Makino K; Kochi M; Saya H; Kuratsu J; Ushio Y Cancer; 2002 Jul; 95(2):249-57. PubMed ID: 12124823 [TBL] [Abstract][Full Text] [Related]
2. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses. Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587 [TBL] [Abstract][Full Text] [Related]
3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
4. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Pollack IF; Hamilton RL; Finkelstein SD; Campbell JW; Martinez AJ; Sherwin RN; Bozik ME; Gollin SM Cancer Res; 1997 Jan; 57(2):304-9. PubMed ID: 9000573 [TBL] [Abstract][Full Text] [Related]
5. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry. von Eckardstein K; Gries H; Bolik E; Cervós-Navarro J; Tschairkin IN; Patt S Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141 [TBL] [Abstract][Full Text] [Related]
6. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715 [TBL] [Abstract][Full Text] [Related]
7. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas. Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927 [TBL] [Abstract][Full Text] [Related]
8. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Pollack IF; Finkelstein SD; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Finlay JL; Sposto R; Cancer Res; 2001 Oct; 61(20):7404-7. PubMed ID: 11606370 [TBL] [Abstract][Full Text] [Related]
9. Ethnicity delineates different genetic pathways in malignant glioma. Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811 [TBL] [Abstract][Full Text] [Related]
10. TP53 mutations in malignant astrocytomas. Biernat W; Debiec-Rychter M; Kordek R; Liberski PP Pol J Pathol; 1997; 48(4):221-4. PubMed ID: 9529927 [TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors. Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588 [TBL] [Abstract][Full Text] [Related]
13. Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations. Tada M; Matsumoto R; Iggo RD; Onimaru R; Shirato H; Sawamura Y; Shinohe Y Cancer Res; 1998 May; 58(9):1793-7. PubMed ID: 9581814 [TBL] [Abstract][Full Text] [Related]
14. p53 alteration is not an independent prognostic indicator, but affects the efficacy of adjuvant chemotherapy in human pancreatic cancer. Dong M; Nio Y; Yamasawa K; Toga T; Yue L; Harada T J Surg Oncol; 2003 Feb; 82(2):111-20. PubMed ID: 12561067 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions. Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501 [TBL] [Abstract][Full Text] [Related]
16. Expression and mutation analysis of the p53 gene in astrocytoma. Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271 [TBL] [Abstract][Full Text] [Related]
17. Functional evaluation of p53 and PTEN gene mutations in gliomas. Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241 [TBL] [Abstract][Full Text] [Related]
18. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations. Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620 [TBL] [Abstract][Full Text] [Related]
19. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme. Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157 [TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery]. Wang YY; Bao XF; Li SY; Wu CY Ai Zheng; 2002 Oct; 21(10):1149-53. PubMed ID: 12508664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]